Gene Expression and Manipulation

Information

  • Research Project
  • 10250835
  • ApplicationId
    10250835
  • Core Project Number
    P30EY010572
  • Full Project Number
    5P30EY010572-27
  • Serial Number
    010572
  • FOA Number
    PAR-17-322
  • Sub Project Id
    5452
  • Project Start Date
    5/1/1997 - 27 years ago
  • Project End Date
    8/31/2025 - a year from now
  • Program Officer Name
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    27
  • Suffix
  • Award Notice Date
    9/9/2021 - 2 years ago

Gene Expression and Manipulation

PROJECT SUMMARY - GENE EXPRESSION AND MANIPULATION The Gene Expression and Manipulation Module is focused on providing support, and assisting and facilitating specific studies relating to gene expression and manipulation. Most of the types of studies we support fall within the range of ocular molecular biology, biochemistry and cell biology. This includes evaluating, quantitatively, the temporal effects of treatments, conditions or disease states on the expression levels, mRNA and protein, of genes in ocular tissues. We also support studies focused on determining the effects of individual gene manipulation on ocular processes and cells. This includes knockdown of specific gene expression levels in cells or tissues by RNAi silencing, increases in specific gene expression by overexpression, and modulation of activity or function of specific genes by expressing modified forms, e.g. by transfecting or infecting genetic mutant, dominant negative, constitutively active or alternatively spliced gene constructs. Manipulation methods include construct transfection and viral gene or RNAi delivery via infection with recombinant viral constructs. Expression studies using PCR Arrays and cis element promoter studies are also facilitated. We have recently been assisting investigators with CRISPR/Cas9 gene editing studies aimed at disease modeling with the intention of future disease related modifications and stem cell manipulation. We have and maintain instrumentation that supports these types of studies. We have experience with all of these methods and will facilitate and assist core users with any that they deem of value to their investigations. In addition to providing this service to NEI-funded investigators, we actively support efforts of investigators, particularly new and young investigators, to develop pilot or preliminary data that can be leveraged into future foundation and NEI funding.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    P30
  • Administering IC
    EY
  • Application Type
    5
  • Direct Cost Amount
    114939
  • Indirect Cost Amount
    62066
  • Total Cost
  • Sub Project Total Cost
    177005
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NEI:177005\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZEY1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    OREGON HEALTH & SCIENCE UNIVERSITY
  • Organization Department
  • Organization DUNS
    096997515
  • Organization City
    PORTLAND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    972393098
  • Organization District
    UNITED STATES